A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis.

We observed greater clinical improvement in mice treated with Lactibiane iki (AUC: 62.78 ± 23.63, n = 17, p = 0.008) than in vehicle-treated mice (AUC: 80.57 ± 10.82, n = 17), but still, Vivomixx treatment did not reach statistical significance (AUC: 69.47 ± 20.49, n = 17, p = 0.057) ( Figure 1 e,f). 3.2.

also in 111,027 other papers